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EDITORIAL OPEN
npj Primary Care Respiratory Medicine broadens its focus to
include global respiratory health, tobacco control and
implementation science
npj Primary Care Respiratory Medicine  (2017) 27:40 ;
doi:10.1038/s41533-017-0044-8
npj Primary Care Respiratory Medicine (npjPCRM) is dedicated to
promoting high quality research in respiratory diseases in primary
care that has the most signiﬁcant impact on human health,
globally. With the change in leadership following Paul Stephen-
son’s unparalleled commitment to establishing npj PCRM (and its
previous incarnations over the past two decades) as the ﬂagship
journal it now is, there is the opportunity to build on the journal’s
ﬁrm foundations and strategically extend its remit. This editorial is
an invitation to colleagues to submit research showing how
interdisciplinary science can tackle the rising burden of respiratory
diseases. In particular, we are inviting authors to submit work
focusing on global respiratory health, smoking and tobacco
control, and implementation science.
As in most other health conditions, huge disparities exist in the
burden of respiratory diseases across the globe. Eighty-three per
cent of the 9.3 million deaths worldwide in 2015 due to chronic
lung diseases, lower respiratory infections, lung cancer and
tuberculosis occurred in low-income and middle-income countries
(LMICs).1 There are also differences in their distribution and
determinants e.g., chronic obstructive pulmonary disease (COPD)
is common among men who smoke in Europe and the United
States, while in Asia it is predominantly a disease among women
who use biomass fuel for cooking.2 If knowledge is an instrument
to improve health then the well-described 10/90 gap between
disease burden and health research depicts a gross neglect of the
health of those living in LMICs.3 There are no simple solutions to
address this gap. To make progress we need to embrace global
health’s vision of equity for all people worldwide, which
recognises our interdependence to address health issues that
transcends national boundaries.4 Medical journals, by publishing
new knowledge that is relevant and accessible to all its potential
benefactors, can play an important role in closing this 10/90 gap.
Access to relevant information can help replace the paternalistic
and asymmetrical relationships often found in ‘development aid’
with that of interdependence and sharing of resources–a basis for
‘global solidarity’.5 In the International Primary Care Respiratory
Group, npjPCRM has an ideal partner to extend this invitation to
the broad community of global health stakeholders and to
become an inclusive forum for debate and discussion relevant to
lung health. npjPCRM will continue to publish work and the
opinions of academics and practitioners working in respiratory
medicine irrespective of their geographical location. However, we
would particularly like to encourage and support those working in
LMICs to submit their best work.
Tobacco use has long been recognised as the single most
important preventable cause of most respiratory illnesses.
Common conditions such as COPD and lung cancer account for
a large proportion of deaths attributable to smoking.2 Hence,
preventing, stopping and protecting from smoking are key to
manage respiratory diseases.6 Brief advice by general practitioners
encouraging all smokers to quit remains one the most cost-
effective intervention in healthcare.7 In those with COPD, quitting
cigarettes is the most effective intervention in stopping disease
progression and reducing associated morbidity and mortality.8
Even in lung cancer patients, smoking cessation improves survival,
treatment efﬁcacy and quality of life.9 While practitioners in
primary care and respiratory medicine have long been advocating
for strong tobacco control policies and provision of smoking
cessation services, their scholarly work has not yet been centre
stage in the academic forums of respiratory medicine. Recognising
this gap, npjPCRM is proactively seeking submissions in this area
that reﬂect the diverse and interdisciplinary nature of work that
goes on in tobacco control.
While calls to bridge the evidence-into-practice gap in health
and healthcare are not new, implementation science10 has
emerged more recently as an academic discipline in its own
right. The study of methods to promote knowledge uptake into
policy and practice is now recognised to be just as important as
knowledge generation itself. If medical science is to have an
impact it is through showing not just its internal validity, but also
its relevance to a diverse ‘real world’ context. With initiatives such
as the Standards for Reporting Implementation Studies,11 there
need not be any compromise in the rigour and reporting of
implementation research. Implementation science is distinguished
by its interdisciplinary nature and explicit use of theories. Whether
it is a trial with real word relevance or an evaluation embedded in
implementation, a genuine partnership is required between
scientists across different disciplines and those responsible for
implementing ﬁndings. Similarly, implementation science requires
an appropriate conceptual framework often rooted within
organisational and professional behaviour change theories. In
respiratory medicine, implementation science can take many
forms,12 such as: observational studies of evidence-into-practice
gaps, qualitative research to understand barriers/facilitators
relevant to routine delivery of care, process evaluations aiming
to understand the mechanisms and contexts; assessing outcomes
such as intervention reach, sustainability, and adoption; and use of
step-wedge randomised controlled trials and natural experiment
designs to evaluate interventions. We recognise that implementa-
tion science in any disease area would beneﬁt from different
strands of evidence coming together. Therefore, npjPCRM would
welcome submissions in any of the above genres including
studies using methods rooted in social sciences.
At npj PRCM we remain resolute in our efforts to publish and
celebrate the very best science addressing applied respiratory
research questions of direct relevance to primary care. Strategi-
cally expanding our remit to encourage submission in global
health, tobacco control and implementation science will broaden
the base from which we tackle key respiratory challenges and to
this end we look forward to receiving your contributions.
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